Delivery Order SPE2DB22D2009-SPE2DB24FM1VT
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$101K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML medical products. The contract, valued at $12,438.60, was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 15, 2024. The contract does not have a set-aside designation, indicating...
This federal contract award is a delivery order valued at $13,426.20 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a completion date of July 8, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $70,908.00, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and a completion date of September 6, 2023. The award was not designated with a set-aside requirement. Amerisourcebergen Drug Corp is a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $325,426.28. It is for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of July 9, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award is a Delivery Order valued at $4,586.26, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a performance period extending through May 16, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is a delivery order valued at $9,132.75 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565710065 MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract is a firm fixed price arrangement with an ultimate completion date of September 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs)...
This federal contract award is for the delivery of pharmaceutical products and medical supplies, specifically MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $12,955.78 and an ultimate completion date of November 17, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract...
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $53,519.40, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2024. This is a firm fixed-price delivery order contract with a completion date of December 17, 2024. The contract is not designated as a set-aside award. Amerisourcebergen, a for-profit...
This federal contract award is for the delivery of Menveo 1 vial-A-C-Y-W-135-DIP 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $112,034.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price pricing type and an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $17,420.01 firm-fixed-price delivery order is for the supply of MENVEO 1 vial-A-C-Y-W-135-DIP 0.5ML pharmaceutical products, with an ultimate completion date of August 14, 2024. There is no set-aside designation for this contract. Amerisourcebergen, a major supplier of pharmaceutical and medical products to the U.S. government, holds several...